Related Experiment Video
Updated: May 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
What information should a sponsor of a randomized trial receive during its conduct?
Sonia S Anand1, Janet Wittes, Salim Yusuf
1Department of Medicine and Epidemiology, McMaster University, Hamilton, Ontario, Canada. anands@mcmaster.ca
Background:
The relationship and roles among the steering committee, the Data Safety Monitoring Board (DSMB), and the sponsor of a randomized clinical trial (RCT) must be carefully defined to ensure the integrity of the trial.
Purpose:
We present an unusual scenario that arose during the conduct of a large RCT in Canada that involved the relationship of the steering committee and the DSMB with the peer review sponsor.
Methods:
Case study of a large RCT conducted in Canada and a commentary on the roles and responsibilities of the steering committee, DSMB, and sponsor.
Conclusions:
This case illustrates the need for funding agencies to understand the importance of respecting the independence of the DSMB and the need to keep confidential emerging trends regarding study results, including the conditional probability, during the conduct of a trial.
More Related Videos
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blinding
Randomized Experiments
Simple randomization
Simple...
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blind Procedures

